Eagle Pharmaceuticals
EGRX
#10088
Rank
S$8.84 M
Marketcap
$0.68
Share price
0.00%
Change (1 day)
-90.86%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): S$47.63 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are S$0.25 Billion. In 2022 the company made an earning of S$89.88 Million, an increase over its 2021 earnings that were of -S$3.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) S$47.63 M-47.01%
2022 S$89.88 M-2361.45%
2021 -S$3.98 Million-111.53%
2020 S$34.45 M2.31%
2019 S$33.68 M-32.89%
2018 S$50.18 M-50.35%
2017 S$0.10 B38.63%
2016 S$72.91 M1966.43%
2015 S$3.52 M-111.46%
2014 -S$30.81 Million282.82%
2013 -S$8.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$25.09 B 51,485.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.69 B 11,596.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$17.37 B 35,604.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$0.57 B 1,077.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
S$6.38 B 13,021.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.85 B 28,365.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$9.39 Billion-19,393.87%๐Ÿ‡บ๐Ÿ‡ธ USA